The follicular lymphoma treatment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Follicular Lymphoma Treatment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The follicular lymphoma treatment market size has grown strongly in recent years. It will grow from $2.83 billion in 2023 to $3.09 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increased incidence of follicular lymphoma, advancements in cancer diagnostics, expanding aging population, clinical research and drug development, collaborations in oncology research.
The follicular lymphoma treatment market size is expected to see strong growth in the next few years. It will grow to $4.2 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to personalized medicine approaches, immunotherapy advancements, expanded access to innovative therapies, focus on quality of life, global oncology collaboration initiatives. Major trends in the forecast period include clinical trials and research initiatives, exploration of epigenetic modifiers, enhancements in radioimmunotherapy, application of artificial intelligence (ai), global collaboration for access to therapies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/follicular-lymphoma-treatment-global-market-report
Scope Of Follicular Lymphoma Treatment Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Follicular Lymphoma Treatment Market Overview
Market Drivers –
The rising prevalence of follicular lymphoma is expected to propel the growth of the follicular lymphoma treatment market moving forward. The prevalence of follicular lymphoma refers to the total number or proportion of individuals within a specific population diagnosed with follicular lymphoma at a given time or over a particular period. This shift has resulted from the rise in the aging population, genetic predisposition, improved diagnostic techniques, and increased awareness and screening. Follicular lymphoma treatment helps reduce the prevalence of follicular lymphoma by addressing the disease at various stages and aids in disease treatment and progression. The rise in the incidence of follicular lymphoma is boosting the growth of the follicular lymphoma treatment market. For instance, in January 2023, according to the American Cancer Society, a US-based Voluntary organization, non-Hodgkin lymphoma, a type of indolent follicular lymphoma, is the most frequent cancer in the US, accounting for around 4% of all cancers. The American Cancer Society projects that NHL will be diagnosed in approximately 80,550 persons (44,880 men and 35,670 women). This includes both adults and children. Therefore, the rising prevalence of follicular lymphoma is driving the growth of the follicular lymphoma treatment market.
Market Trends –
Technological advancements in the diagnosis and treatment of follicular lymphoma are a key trend-gaining opportunity in the follicular lymphoma treatment market. Companies operating in the follicular lymphoma treatment market are adopting advanced diagnoses and treatments for follicular lymphoma to sustain their position in the market. For instance, in December 2022, Genentech Inc., a US-based biotechnology company, received FDA approval for Lunsumio, a novel bispecific antibody for treating relapsed or refractory follicular lymphoma. This antibody is a new class of fixed-duration cancer treatment immunotherapy, and it is a readily available and off-the-shelf treatment options patients are not needed to wait to receive this immunotherapy treatment. The FDA approval is based on positive results from the Lunsumio Phase II GO29781 research in persons with extensively pretreated FL, particularly those at high risk of illness progression or unresponsive to prior treatments.
The follicular lymphoma treatment market covered in this report is segmented –
1) By Treatment: Monoclonal Antibodies, Targeted Therapy, Chemotherapy, Radiation Therapy, Stem Cell Transplant, Alkylating Agents, Nucleoside Analogues, Anthracycline Derivatives, Other Treatments
2) By Product Type: Tablets, Capsules, Injectables, Other Product Types
3) By Route of Administration: Oral, Parenteral, Other Route of Administration
4) By End Use: Hospitals, Oncology Centers, Ambulatory Care Centers, Academic Research Institutes, Other End Users
Get an inside scoop of the follicular lymphoma treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10758&type=smp
Regional Insights –
North America was the largest region in the follicular lymphoma treatment market in 2023. The regions covered in the follicular lymphoma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the follicular lymphoma treatment market report are AbbVie Inc.,Celgene Corporation,Bayer AG,Bristol Myers Squibb Company,F. Hoffmann-La Roche Ltd.,Johnson and Johnson Services Inc.,GlaxoSmithKline plc,Novartis AG,Merck & Co. Inc.,EpiZyme Inc.,Boehringer Ingelheim GmbH,CTI BioPharma Corp.,Spectrum Pharmaceuticals Inc.,Seattle Genetics Inc.,Applied Molecular Genetics Inc.,Daiichi Sankyo Company Ltd.,Pfizer Inc.,Incyte Corporation,MorphoSys AG,Regeneron Pharmaceuticals Inc.,Eli Lilly and Company,Seagen Inc.,Takeda Pharmaceutical Company,Abbott Laboratories, Nordic Nanovector ASA,ADC Therapeutics SA,MEI Pharma Inc.,BeiGene Inc.,TG Therapeutics Inc.,Amgen Inc.,Dr. Reddy’s Laboratories Ltd.
Table of Contents
1. Executive Summary
2. Follicular Lymphoma Treatment Market Report Structure
3. Follicular Lymphoma Treatment Market Trends And Strategies
4. Follicular Lymphoma Treatment Market – Macro Economic Scenario
5. Follicular Lymphoma Treatment Market Size And Growth
…..
27. Follicular Lymphoma Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
